Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Alcohol Clin Exp Res. 2021 Mar 17:10.1111/acer.14601. doi: 10.1111/acer.14601

Table 4.

Summary of Monetary Outcomes, Benefits, Net Benefits, and Benefit-Cost Ratios

TAU CBT4CBT+TAU CBT4CBT+monitoring
Mean (winsorized)$ Median $ SD Mean (winsorized)$ Median $ SD Mean (winsorized)$ Median $ SD
Baseline monthly sum of monetary outcomes $499.15 $434.78 $447.44 $318.61 $117.92 $624.25 $390.03 $211.30 $500.61
6-month follow-up monthly sum of monetary outcomes $722.06 $86.89 $1,681.60 $146.32 $36.26 $386.92 $276.14 $56.48 $467.50
6-month cost-saving benefitsa −$222.91 ($77.30) $98.15 $1,797.83 $172.29 ($106.61) $38.91 $702.53 $113.89 ($87.91) $0.00 $723.51
Net benefits −$1,568.51 (−$705.60) −$326.93 $3,782.61 −$344.16 (−$409.84) −$363.30 $676.90 −$267.33 (−$294.23) −$311.64 $734.33
Benefit-cost ratio .35 (.46) .14 2.69 .13 (.04) .08 1.68 .08 (.03) .00 3.05

Note. N = 57 for all variables

a

Baseline monthly sum of monetary outcomes minus 6-month follow-up monthly sum of monetary outcomes.